References
  1. Frati F, Incorvaia C, Passalacqua G. Efficacy of sublingual immunotherapy. JAMA 2013;310(6):643-644
  2. Calamita Z, Saconato H, Bronhara Pelà A, Nagib Atallah A. Efficacy of sublingual immunotherapy in asthma. Systematic review of randomized clinical trials. Allergy 2006;61:1162-72
  3. Melaranci C, Matteoli MC. Efficacy of allergoid sublingual immunotherapy in children with asthma and/or allergic rhinoconjunctivitis. JACI 2004;113:S111
  4. Cuppari C, Leonardi S, Manti S, Filippelli M, Alterio T, Spicuzza L, Rigoli L, Arrigo T, Lougaris V, Salpietro C. Allergen immunotherapy, routes of administration and cytokine networks: an update. Immunotherapy 2014;6(6):775-86.
  5. Pastorello EA, Losappio L, Milani S, Manzotti G, Fanelli V, Pravettoni V, Agostinis F, D’Arcais AF, Dell’Albani I, Puccinelli P, Incorvaia C, Frati F. 5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs: a real-life study. J Asthma Allergy 2013;6:127-33.
  6. Kabisch M, Ruckes C, Seibert-Grafe M, Blettner M. Randomized controlled trials: part 17 of a series on evaluation of scientific publications. Dtsch Arztebl Int 2011;108(39):663-8.
  7. Bousquet J, Khaltaev N, Cruz AA, et al. World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy 2008;63(Suppl. 86):8-160
  8. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Available at: https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf. Last Access: July 26, 2022
  9. Klimek L, Bergmann KC, Biedermann T, Bousquet J, Hellings P, Jung K, Merk H, Olze H, Schlenter W, Stock P, Ring J, Wagenmann M, Wehrmann W, Mösges R, Pfaar O. Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, Allergology and Environmental Medicine of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC). Allergo J Int 2017;26(1):16-24.
  10. Rhee H, Belyea M, Mammen J. Visual analogue scale (VAS) as a monitoring tool for daily changes in asthma symptoms in adolescents: a prospective study. Allergy Asthma Clin Immunol 2017;13:24.
  11. Meltzer EO, Busse WW, Wenzel SE, Belozeroff V,Weng HH, Feng J, Chon Y, et al. Use of the asthmacontrol Questionnaire to predict future risk of asthma exacerbation. J Allergy Clin Immunol 2011;127:167–172.
  12. Manti S, Licari A. How to obtain informed consent for research. Breathe (Sheff). 2018;14(2):145-152
  13. De Vos C, Mitchev K, Pinelli M-E, et al. Non-interventional study comparing treatment satisfaction in patients treated with antihistamines. Clin Drug Investig 2008;28:221-30
  14. Ferrer M, Morais-Almeida M, Guizova M, et al. Evaluation of treatment satisfaction in children with allergic disease treated with an antihistamine: an international, non-interventional, retrospective study. Clin Drug Investig 2010;30:15-34
  15. Zicari AM, Indinnimeo L, De Castro G, Incorvaia C, Frati F, Dell’Albani I, Puccinelli P, Scolari M, Duse M; Pediatric SURF Study Group. A survey on features of allergic rhinitis in children. Curr Med Res Opin. 2013;29(5):415-20
  16. Wang T, Li Y, Wang F, Zhou C. Nonadherence to sublingual immunotherapy in allergic rhinitis: a real-life analysis. Int. Forum Allergy Rhinol 2017;7:389–392
  17. Kiotseridis H, Arvidsson P, Backer V, Braendholt V, Tunsäter A. Adherence and quality of life in adults and children during 3-years of SLIT treatment with Grazax-a real life study. NPJ Prim Care Respir Med 2018;28(1):4
  18. Ras L, de Groot H, Stengs CH, van Weissenbruch R. Persistence of treatment with 5-grass pollen tablets in patients with allergic rhinitis: a real-life study. Ann Allergy Asthma Immunol. 2016;116(1):52-58.e2
  19. Pajno GB, Caminiti L, Crisafulli G, Barberi S, Landi M, Aversa T, Valenzise M, Passalacqua G. Adherence to sublingual immunotherapy in preschool children. Pediatr Allergy Immunol. 2012;23(7):688-9.
  20. Halken S, Larenas-Linnemann D, Roberts G, et al. EAACI guidelines on allergen immunotherapy: prevention of allergy. Pediatr Allergy Immunol 2017;28(8):728–745.
  21. Valovirta E, Petersen TH, Piotrowska T, Laursen MK, Andersen JS, Sørensen HF, Klink R; GAP investigators. Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy. J Allergy Clin Immunol 2018;141(2):529–538 e513
  22. Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy 2006;61(2):198–201.
  23. Passalacqua G, Frati F, Puccinelli P, Scurati S, Incorvaia C, Canonica GW, Hilaire C. Adherence to sublingual immunotherapy: the allergists’ viewpoint. Allergy 2009;64(12):1796-7.
  24. Brüggenjürgen B, Reinhold T. Cost-effectiveness of grass pollen subcutaneous immunotherapy (SCIT) compared to sublingual immunotherapy (SLIT) and symptomatic treatment in Austria, Spain, and Switzerland. J Med Econ 2018;21(4):374-381.
  25. Osterberg L, Blashke T. Adherence to medication. N Engl J Med. 2005;353:487–93
  26. Sabaté E. Adherence to long-term therapies: evidence for action. Switzerland: World Health Organization; 2003. World Health Organization. https://apps.who.int/iris/handle/10665/42682
  27. Bidwal M, Lor K, Yu J, Ip E. Evaluation of asthma medication adherence rates and strategies to improve adherence in the underserved population at a Federally Qualified Health Center. Res Soc Adm Pharm 2017;13:759–66.
  28. Senna G, Caminati M, Lockey RF. Allergen immunotherapy adherence in the real world: how bad is it and how can it be improved? Curr Treat Options Allergy 2015;2:14.
  29. Paoletti G, Di Bona D, Chu DK, Firinu D, Heffler E, Agache I, Jutel M, Klimek L, Pfaar O, Mösges R, DunnGalvin A, Genuneit J, Hoffmann HJ, Canonica GW. Allergen immunotherapy: The growing role of observational and randomized trial ”Real-World Evidence”. Allergy. 2021;76(9):2663-2672.
  30. Di Bona D, Paoletti G, Chu DK, Pepys J, Macchia L, Heffler E, Canonica GW. Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis. Clin Transl Allergy 2021;11(4):e12033